A Study in Healthy Male Subjects to Investigate Whether Administration of ACT-132577 Can Affect Rosuvastatin's Fate in the Body (Amount and Time of Presence in the Blood)
Clinical trial NCT03245229 · COMPLETED
Trial details
- NCT number
- NCT03245229
- Sponsor
- Idorsia Pharmaceuticals Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-10
- Primary completion
- 2017-09-18
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.